Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

BIO Welcomes First Chinese Members: Shanghai Zhangjiang Park And Taizhou Medical City

This article was originally published in PharmAsia News

Executive Summary

SHANGHAI - BIO, the largest biotechnology organization with 1,200 members around the world, announced its first two members from China - Zhangjiang Hi-tech Park in Shanghai and China Medical City in Taizhou - during the group's annual convention in Chicago
Advertisement

Related Content

With Government Support, China Medical City Looks To Separate Itself From The Pack
PhRMA Teams Up With Chinese Trade Group To Focus On IP Rights, Data Protection
PhRMA Teams Up With Chinese Trade Group To Focus On IP Rights, Data Protection
PPD Opens Vaccine Clinical Research Center In Taizhou: One Step Closer To Its Goal To Become China's Number One Service Provider
Hutchison Medipharma Initiates Phase I Trials Of Cancer-fighting Candidate Sulfatinib In China
WuXi PharmaTech Founder Ge Li Says Upcoming Merger With Charles River Is Part Of Globalization Of The Drive To Save Lives
WuXi PharmaTech Founder Ge Li Says Upcoming Merger With Charles River Is Part Of Globalization Of The Drive To Save Lives
China's Contract Manufacturing Growth Tied To Losses In The West
PPD Acquires China-based CRO Excel To Continue Global Expansion
Biopharma Industry Slated As China Pillar Industry, But Key Domestic Support Missing
Advertisement
UsernamePublicRestriction

Register

SC074807

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel